One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...

Leaders from the WHO responded with a statement saying that the organization hopes the United States will reconsider. “WHO ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

Kamilia Smith, MD, FACOG, NCMP, discusses how vasomotor symptoms (VMS) significantly impact sleep quality while examining the evolving landscape of VMS management, including both current treatment ...

Appearing to stick closely to what was shown on teleprompters to the left and right of the podium with the familiar ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, ...

As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating ...